Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of Armodafinil on Cognition in Multiple Sclerosis: A Randomized, Double-blind Crossover Pilot Study.
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
Multiple sclerosis: Generic glatiramer acetate - a step toward cheaper MS drugs?
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
Inhibition of Endogenous Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis by Inducing Myeloid-Derived Suppressor Cells.
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
Information processing speed and attention in multiple sclerosis: Reconsidering the Attention Network Test (ANT).
[Therapeutic options for autoimmune encephalomyelitis].
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
Wnt and lithium: a common destiny in the therapy of nervous system pathologies?
Acute disseminated encephalomyelitis following biting by a scolopendra subspinipes mutilans.
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
Vitamin D deficiency in multiple sclerosis: Should testing and treatment be based on racial background?
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors.
Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
Goodbye to all that: a short history of CCSVI.
Observation Gait Assessments in subjects with neurological disorders: A Systematic Review.
Pages
« first
‹ previous
…
410
411
412
413
414
415
416
417
418
…
next ›
last »